Oryx Communities has submitted revised plans for its aged care project in Nedlands, after community backlash led the group to pursue the State Development Assessment Unit.
Nexus Minerals has launched a $6.6 million share placement to fund a feasibility study on the company’s gold joint venture with Saracen Mineral Holdings.
South Australian Premier Steven Marshall's move to quash his state's COVID-19 outbreak has been praised by Western Australian counterpart Mark McGowan.
Perth-based Sentient Computing has added 12 staff to its team after winning new contracts for its virtual reality training and 3D visualisation services.
As his final year in parliament wraps up, Mike Nahan reflects on his passion for free-market values, a guiding force during his time as state treasurer.
The Takeovers Panel has rejected a request from Perth-based Cardinal Resources to improve separate takeover offers from Russian mining giant Nordgold and China’s Shandong Gold.
Crown has declared it will stop dealing with all junket operations as it continues its bid to persuade the NSW gaming regulator that the public company is fit to run a new $2.2 billion casino in Sydney.
Buy now, pay later giants Afterpay and Zip are unlikely to face more regulatory challenges despite government research showing one in five customers of such providers miss payments.
Reserve Bank governor Philip Lowe says a rapid economic recovery is possible if there is further good news on the health front, such as a COVID-19 vaccine.
Australia's share market finished higher but trade was suspended for most of the day after the introduction of a new trading system did not go as planned.
Western Australian companies Dacian Gold and NTM Gold have agreed to merge their assets, with the combined group to have a market capitalisation of $285 million.
National recruitment firm Building Careers Australia was on shaky ground in its legal action against former state director Lezly D’Limi, the Supreme Court has found.
Medicinal cannabis company AusCann Group Holdings has bought in to the animal health sector after announcing its acquisition of NSW business CannPal Animal Therapeutics.
A new flu vaccine manufacturing plant will be built in Melbourne to guard against future pandemics and provide antivenoms for some of Australia's most deadly creatures.